TARGINIQ
These highlights do not include all the information needed to use TARGINIQ™ ER safely and effectively. See full prescribing information for TARGINIQ ER. TARGINIQ ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), for oral use, CIIInitial U.S. Approval: 2014
98e70c9c-fa3c-e63f-41d4-dac3c6fec51d
HUMAN PRESCRIPTION DRUG LABEL
Dec 22, 2016
Purdue Pharma LP
DUNS: 932323652
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Oxycodone hydrochloride/naloxone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Oxycodone hydrochloride/naloxone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Oxycodone hydrochloride/naloxone hydrochloride
Product Details
FDA regulatory identification and product classification information